Structural Formula (Bumetanide Injection Usp Novaplus 1)
Bumetanide Injection
Product Images NDC 0641-6285
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Bumetanide (NDC 0641-6285). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Pi Black Ww Logo (Bumetanide Injection Usp Novaplus 2)
This is a prescription medication with the NDC code 0641-6161-01. The drug is bumetanide, an injection used for intravenous (IV) or intramuscular (IM) use. This single dose vial contains 4 mL of solution at 1mg per 4 mL, with 0.25 mg/m! concentration. The solution contains benzyl alcohol as a preservative, and each mL contains bumetaride 0.25 mg, sodium chloride 8.5 mg and ammo-nium acetate 4 mg as buffering agents, edetate disodium 0.1 mg, and benzyl alcohol 10 my. The pH is adjusted to 6.8-7.8 with sodium hydroxide, and it is non-latex. The usual dosage should be consulted in the package insert. The drug should be stored at 20-25°C (68-77°F) and protected from light. The manufacturer is Hima and is located in Berkeley Heights, NJ 07522.*
4 mL Vial Container Label (Bumetanide Injection Usp Novaplus 3)
This appears to be a product label for an injection medication containing bumetanide, sodium chloride, and ammo. The medication is administered by IV or IM and should be stored between 20-25°C. The dosage instructions are not included in the text, however, they should be available in the package insert. The product comes in single-dose vials.*
10 X 4 mL Vial Shelfpack Label (Bumetanide Injection Usp Novaplus 4)
This is a description of a medication labeled as NOC 0641616201 Ronly Bumetanide injection, USP IR. It contains the active ingredient bumetanide in 0.25 mg concentration in each milliliter of solution, along with sodium chloride, ammonium acetate, and edetate sodium. The medication comes in a 10mL multi-dose vial and is intended for intravenous or intramuscular use only. The solution contains benzyl alcohol as a preservative and has a pH adjusted to 8.7 using sodium hydroxide. The medication should be stored between 12-25°C. This description also includes a reference to a package insert that provides the usual dosage information.*
462-706-00 10 mL Vial (Bumetanide Injection Usp Novaplus 5)
This is a drug description for Bumetanide Injection, USP, with NDC number 0641-6162-10. It is a solution for intravenous or intramuscular use, containing 2.5mg per 10mL of the drug. Each milliliter (ml) of the solution comprises of bumetanide at 0.25mg, sodium chloride at 8.5mg, ammonium acefate at 4mg as buffers, edetate-disodium at 0.1mg, and benzyl alcohol. The drug should be stored at a temperature range of 20°C to 25°C (68°F to 77°F), protected from tight spaces.*
462-707-00 10 X 10 mL Vial Shelfpack (Bumetanide Injection Usp Novaplus 6)
This text provides product information including the GTIN (Global Trade Item Number), SN (Serial Number), EXP (Expiration Date), and LOT (Lot Number). The specific values for these variables are not available in the given text.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
